Correlation Between Bluejay Diagnostics and Vivos Therapeutics

Can any of the company-specific risk be diversified away by investing in both Bluejay Diagnostics and Vivos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bluejay Diagnostics and Vivos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bluejay Diagnostics and Vivos Therapeutics, you can compare the effects of market volatilities on Bluejay Diagnostics and Vivos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bluejay Diagnostics with a short position of Vivos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bluejay Diagnostics and Vivos Therapeutics.

Diversification Opportunities for Bluejay Diagnostics and Vivos Therapeutics

-0.19

Correlation Coefficient

Bluejay Diagnostics  Vivos Therapeutics

Good diversification

The 3 months correlation between Bluejay and Vivos is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Bluejay Diagnostics and Vivos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vivos Therapeutics and Bluejay Diagnostics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bluejay Diagnostics are associated (or correlated) with Vivos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vivos Therapeutics has no effect on the direction of Bluejay Diagnostics i.e., Bluejay Diagnostics and Vivos Therapeutics go up and down completely randomly.

Pair Corralation between Bluejay Diagnostics and Vivos Therapeutics

Given the investment horizon of 90 days Bluejay Diagnostics is expected to generate 2.29 times more return on investment than Vivos Therapeutics. However, Bluejay Diagnostics is 2.29 times more volatile than Vivos Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Vivos Therapeutics is currently generating about -0.2 per unit of risk. If you would invest  164.00  in Bluejay Diagnostics on July 15, 2025 and sell it today you would earn a total of  155.00  from holding Bluejay Diagnostics or generate 94.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Bluejay Diagnostics  vs.  Vivos Therapeutics

Bluejay Diagnostics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Bluejay Diagnostics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile fundamental indicators, Bluejay Diagnostics showed solid returns over the last few months and may actually be approaching a breakup point.

Vivos Therapeutics

Risk-Adjusted Performance

Weakest

Over the last 90 days Vivos Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in November 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Bluejay Diagnostics and Vivos Therapeutics

The main advantage of trading using opposite Bluejay Diagnostics and Vivos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bluejay Diagnostics position performs unexpectedly, Vivos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vivos Therapeutics will offset losses from the drop in Vivos Therapeutics' long position.

The idea behind Bluejay Diagnostics and Vivos Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.